In March 2025, the company introduced new strategies for a immediate-to-client providing of its Wegovy weight loss drug. The company recognized a brand new pharmacy, called NovoCare, which would demand prospects $499 every month for use of the drug, lower than half the cost of the drug by way of other pharmaceutical distribution networks.[fifty thr